Public Equities, L.P.Minne ... Net Worth

The estimated Net Worth of Public Equities, L.P.Minne ... is at least $716 mil dollars as of 3 November 2020. Public Minne owns over 465,000 units of SQZ Biotechnologies Co stock worth over $715,771 and over the last 4 years Public sold SQZ stock worth over $0.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Public Minne SQZ stock SEC Form 4 insiders trading

Public has made over 2 trades of the SQZ Biotechnologies Co stock since 2020, according to the Form 4 filled with the SEC. Most recently Public bought 465,000 units of SQZ stock worth $7,440,000 on 3 November 2020.

The largest trade Public's ever made was buying 800,000 units of SQZ Biotechnologies Co stock on 16 June 2020 worth over $15,200,000. On average, Public trades about 632,500 units every 70 days since 2020. As of 3 November 2020 Public still owns at least 1,606,308 units of SQZ Biotechnologies Co stock.

You can see the complete history of Public Minne stock trades at the bottom of the page.

Insiders trading at SQZ Biotechnologies Co

Over the last 4 years, insiders at SQZ Biotechnologies Co have traded over $3,939 worth of SQZ Biotechnologies Co stock and bought 2,233,026 units worth $35,530,795 . The most active insiders traders include Holdings (Private) Ltd Temasek, Public Equities, L.P.Minne ..., eAmy W Schulman. On average, SQZ Biotechnologies Co executives and independent directors trade stock every 50 days with the average trade being worth of $78,593. The most recent stock trade was executed by Richard Capasso on 15 August 2022, trading 1,183 units of SQZ stock currently worth $3,939.

What does SQZ Biotechnologies Co do?

Complete history of Public Minne stock trades at Generation Bio Co e SQZ Biotechnologies Co

SQZ Biotechnologies Co executives and stock owners

SQZ Biotechnologies Co executives and other stock owners filed with the SEC include:

• Dr. Armon R. Sharei Ph.D.,
  Co-Founder, Pres, CEO, Interim Principal Financial Officer & Director
• Teri Loxam,
  Consultant & Advisor
• Dr. Howard Bernstein M.D., Ph.D.,
  Chief Scientific Officer
• Lawrence J. Knopf,
  Gen. Counsel & Sec.
• Micah Zajic,
  Chief Bus. Officer
• Ipsita Roymoulik Ph.D.,
  Sr. VP of CMC & QUALITY
• Dr. Marshelle Smith Warren M.D.,
  Chief Medical Officer
• David First,
  Chief People Officer
• Dr. Howard Bernstein,
  Chief Scientific Officer
• Richard V. Capasso CPA,
  Chief Accounting Officer
• Dr. Robert S. Langer Jr., Ph.D., Sc.D., SCD,
  Co-Founder & Member of Scientific Advisory Board
• Micah Zajic,
  Chief Financial Officer
• Howard Phd Md Bernstein,
  Interim Chief Executive Office
• Holdings (Private) Ltd Temasek,
  10% owner
• Oliver Rosen,
  Chief Medical Officer
• Paul Bolno,
  Director
• Sapna Srivastava,
  Director
• Teri Loxam,
  Chief Financial Officer
• Pushkal Garg,
  Director
• Klavs F. Jensen,
  Director
• International Group, Inc. A...,
  10% owner
• Marc Elia,
  Director
• David First,
  Chief People Officer
• Armon Sharei,
  President and CEO
• Amy W Schulman,
  Director
• Marc Schegerin,
  Director
• Lawrence J Knopf,
  General Counsel
• Eric Moessinger,
  Director
• Schulman, As Trustee The Ar...,
  10% owner
• Public Equities, L.P.Minne ...,
  
• Management Co. Vii, L.L.C.P...,
  
• Bernard Coulie,
  Director
• Patrick V.J.J. Vink,
  Director
• Richard Capasso,
  See Remarks
• Marshelle Smith Warren,
  Chief Medical Officer